These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26837166)

  • 1. [Advances in the study of site-specific antibody-drug conjugates].
    Sun Y; Huang R; Sun BW
    Yao Xue Xue Bao; 2015 Oct; 50(10):1225-31. PubMed ID: 26837166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the construction of antibody-drug conjugates.
    Chudasama V; Maruani A; Caddick S
    Nat Chem; 2016 Feb; 8(2):114-9. PubMed ID: 26791893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
    Yamada K; Ito Y
    Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-drug conjugates: recent advances in conjugation and linker chemistries.
    Tsuchikama K; An Z
    Protein Cell; 2018 Jan; 9(1):33-46. PubMed ID: 27743348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods to Make Homogenous Antibody Drug Conjugates.
    Kline T; Steiner AR; Penta K; Sato AK; Hallam TJ; Yin G
    Pharm Res; 2015 Nov; 32(11):3480-93. PubMed ID: 25511917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion.
    Dimasi N; Fleming R; Zhong H; Bezabeh B; Kinneer K; Christie RJ; Fazenbaker C; Wu H; Gao C
    Mol Pharm; 2017 May; 14(5):1501-1516. PubMed ID: 28245132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
    Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
    J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for site-specific drug conjugation to antibodies.
    Behrens CR; Liu B
    MAbs; 2014; 6(1):46-53. PubMed ID: 24135651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-Specific Antibody-Drug Conjugation Using Microbial Transglutaminase.
    Dickgiesser S; Deweid L; Kellner R; Kolmar H; Rasche N
    Methods Mol Biol; 2019; 2012():135-149. PubMed ID: 31161507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody drug conjugates.
    Bakhtiar R
    Biotechnol Lett; 2016 Oct; 38(10):1655-64. PubMed ID: 27334710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy.
    Chen H; Lin Z; Arnst KE; Miller DD; Li W
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28763044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development.
    Agarwal P; Bertozzi CR
    Bioconjug Chem; 2015 Feb; 26(2):176-92. PubMed ID: 25494884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marine Antibody-Drug Conjugates: Design Strategies and Research Progress.
    Wang YJ; Li YY; Liu XY; Lu XL; Cao X; Jiao BH
    Mar Drugs; 2017 Jan; 15(1):. PubMed ID: 28098746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency.
    Beerli RR; Hell T; Merkel AS; Grawunder U
    PLoS One; 2015; 10(7):e0131177. PubMed ID: 26132162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugates.
    Liu-Shin L; Fung A; Malhotra A; Ratnaswamy G
    MAbs; 2018; 10(4):583-595. PubMed ID: 29436897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.
    Singh SK; Luisi DL; Pak RH
    Pharm Res; 2015 Nov; 32(11):3541-71. PubMed ID: 25986175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavable linkers in antibody-drug conjugates.
    Bargh JD; Isidro-Llobet A; Parker JS; Spring DR
    Chem Soc Rev; 2019 Aug; 48(16):4361-4374. PubMed ID: 31294429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Site Specific Conjugations of Antibody Drug Conjugates (ADCs).
    Gao W; Zhang J; Xiang J; Zhang L; Wu C; Dhal PK; Chen B
    Curr Cancer Drug Targets; 2016; 16(6):469-79. PubMed ID: 27174056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-selective modification strategies in antibody-drug conjugates.
    Walsh SJ; Bargh JD; Dannheim FM; Hanby AR; Seki H; Counsell AJ; Ou X; Fowler E; Ashman N; Takada Y; Isidro-Llobet A; Parker JS; Carroll JS; Spring DR
    Chem Soc Rev; 2021 Jan; 50(2):1305-1353. PubMed ID: 33290462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of antibody-drug conjugates by mass spectrometry: advances and future trends.
    Huang RY; Chen G
    Drug Discov Today; 2016 May; 21(5):850-5. PubMed ID: 27080148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.